Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

ELECTRONIC TRANSITION --- VIBRONIC TRANSITION --- PLATINUM COMPOUNDS --- ELECTRONIC TRANSITION --- VIBRONIC TRANSITION --- PLATINUM COMPOUNDS

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Cancer --- -Cisplatin --- Platinum compounds --- -Chemotherapy --- Therapeutic use --- Zrzeszenie Artystow Bunt (Poland)

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

NEOPLASMS --- ANTINEOPLASTIC AGENTS --- CAMPTOTHECIN --- PURINES --- DRUG RESISTANCE --- PLATINUM COMPOUNDS --- ANTIBIOTICS, ANTHRACYCLINE --- DRUG THERAPY --- ANALOGS AND DERIVATIVES --- ANALOGS AND DERIVATIVES --- NEOPLASMS --- ANTINEOPLASTIC AGENTS --- CAMPTOTHECIN --- PURINES --- DRUG RESISTANCE --- PLATINUM COMPOUNDS --- ANTIBIOTICS, ANTHRACYCLINE --- DRUG THERAPY --- ANALOGS AND DERIVATIVES --- ANALOGS AND DERIVATIVES

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Clinics --- Cancer --- Respiratory infections --- Chemotherapy --- Platinum compounds --- Personal protective equipment --- Employees --- Health and hygiene --- Treatment --- Threshold limit values

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The platinum-containing chemotherapeutic agents remain key components of many of the most effective regimens for the treatment of cancer. New information about the chemistry, pharmacology and molecular mechanisms by which these drugs work is leading to both the development of new drugs and more effective use of existing members of this class. Better definition of the genetic basis of malignancies is offering intriguing new insights in to how to use these drugs in a more individualized manner. "Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications", edited by Andrea Bonetti, Steve B. Howell, Roberto Leone, and Franco Muggia, provides succinct summaries of the major new developments in field of platinum drug therapy drawn from presentations made at the 10th International Symposium on Platinum Coordination Compounds in Cancer Chemotherapy that took place in Verona, Italy, in December 2007. This meeting, held once every 4 years, brought together the world’s leading investigators working on platinum drugs and their contributions provide a detailed survey of the major research directions in this rapidly evolving field.

Cancer --Chemotherapy. --- Platinum compounds --Therapeutic use. --- Platinum compounds --- Cancer --- Platinum Compounds --- Neoplasms --- Pharmacology --- Congresses --- Antineoplastic Agents --- Drug Therapy --- Biological Science Disciplines --- Therapeutics --- Publication Formats --- Diseases --- Therapeutic Uses --- Inorganic Chemicals --- Natural Science Disciplines --- Chemicals and Drugs --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Pharmacologic Actions --- Publication Characteristics --- Chemical Actions and Uses --- Disciplines and Occupations --- Oncology --- Medicine --- Health & Biological Sciences --- Therapeutic use --- Chemotherapy --- Chemotherapy. --- Therapeutic use. --- Medicine. --- Cancer research. --- Pharmacology. --- Biomedicine. --- Cancer Research. --- Pharmacology/Toxicology. --- Transition metal compounds --- Antineoplastic agents --- Treatment --- Oncology. --- Toxicology. --- Chemicals --- Poisoning --- Poisons --- Tumors --- Toxicology --- Drug effects --- Medical pharmacology --- Medical sciences --- Drugs --- Pharmacy --- Cancer research --- Physiological effect